Markus Carlsson
Research Subjects
Markus Carlsson has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
Anders Larsson
From the Department of Anesthesiology and Intensive Care (MC), Eskilstuna County Hospital, Mälarsjukhuset, Sweden; Section of Anesthesiology and Intensive Care (ML, SR, EM), Department of Surgical Sciences, Uppsala University Hospital, Uppsala, Sweden; Sections of Clinical Chemistry (AL), Clinical Bacteriology (ET), and Infectious Diseases (MC, JS), Department of Medical Sciences, Uppsala University Hospital, Uppsala, Sweden
1 shared publicationEva Mmsc Tano
From the Department of Anesthesiology and Intensive Care (MC), Eskilstuna County Hospital, Mälarsjukhuset, Sweden; Section of Anesthesiology and Intensive Care (ML, SR, EM), Department of Surgical Sciences, Uppsala University Hospital, Uppsala, Sweden; Sections of Clinical Chemistry (AL), Clinical Bacteriology (ET), and Infectious Diseases (MC, JS), Department of Medical Sciences, Uppsala University Hospital, Uppsala, Sweden
1 shared publicationJan Sjölin
From the Department of Anesthesiology and Intensive Care (MC), Eskilstuna County Hospital, Mälarsjukhuset, Sweden; Section of Anesthesiology and Intensive Care (ML, SR, EM), Department of Surgical Sciences, Uppsala University Hospital, Uppsala, Sweden; Sections of Clinical Chemistry (AL), Clinical Bacteriology (ET), and Infectious Diseases (MC, JS), Department of Medical Sciences, Uppsala University Hospital, Uppsala, Sweden
1 shared publicationMats Eriksson
From the Department of Anesthesiology and Intensive Care (MC), Eskilstuna County Hospital, Mälarsjukhuset, Sweden; Section of Anesthesiology and Intensive Care (ML, SR, EM), Department of Surgical Sciences, Uppsala University Hospital, Uppsala, Sweden; Sections of Clinical Chemistry (AL), Clinical Bacteriology (ET), and Infectious Diseases (MC, JS), Department of Medical Sciences, Uppsala University Hospital, Uppsala, Sweden
1 shared publication- Miklos Lipcsey
Department of Surgical Sciences, Anaesthesiology and Intensive Care Medicine, Uppsala University, Uppsala, Sweden
1 shared publication Sten Rubertsson
From the Department of Anesthesiology and Intensive Care (MC), Eskilstuna County Hospital, Mälarsjukhuset, Sweden; Section of Anesthesiology and Intensive Care (ML, SR, EM), Department of Surgical Sciences, Uppsala University Hospital, Uppsala, Sweden; Sections of Clinical Chemistry (AL), Clinical Bacteriology (ET), and Infectious Diseases (MC, JS), Department of Medical Sciences, Uppsala University Hospital, Uppsala, Sweden
1 shared publication
Latest Publications
- 1 March 2009
- Published by Wolters Kluwer Health in Critical Care Medicine
- Vol. 37 (3) , 1031-e4
Inflammatory and circulatory effects of the reduction of endotoxin concentration in established porcine endotoxemic shock—A model of endotoxin elimination
Objective: To study whether a reduction of the endotoxin load, once a generalized inflammatory state has been established, reduces the inflammatory response and endotoxin-induced effects on circulation, hypoperfusion, and organ dysfunction. Design: Prospective parallel-grouped placebo-controlled randomized interventional experimental study. Setting: University research unit. Subjects: Healthy pigs. Interventions: The animals were subjected to a continuous endotoxin infusion rate of either 4.0 or 0.063 μg endotoxin × kg−1 × h−1 for 1, 2, or 6 hours. The 1- and 2-hour infusion groups represented the applied therapy by a reduction of the endotoxin load of 5/6 and 2/3, respectively. Measurements and Main Results: During a 6-hour experiment, laboratory and physiologic parameters were recorded hourly in 26 anesthetized and mechanically ventilated pigs. Primary end point was to detect differences in tumor necrosis factor-α (TNF-α) concentration during the last 3 hours of the experiment. Despite the early reduction of the endotoxin load, no effect on TNF-α concentration was observed. Similarly, in circulatory parameters, such as mean arterial pressure and oxygen delivery, and in platelet count and renal function, no effects were noted. However, there was some improvement in pulmonary compliance and function as determined by Pao2, Paco2, and pH. These changes were associated with slight improvements in leukocyte response and capillary leakage. Conclusions: Termination of the endotoxin infusion represents an incontestable model of endotoxin concentration reduction. Endotoxin elimination strategies applied at the TNF-α peak or later will have very little or no effect on TNF-α–mediated toxicity. Nevertheless, there was an effect on the leukocyte response that was associated with an improvement in respiratory function and microcirculation, making it impossible to rule out fully the beneficial effect of this strategy. However, the effects were limited in relation to the magnitude of the endotoxin concentration reduction and the very early application of the antiendotoxin measure.
- 1 March 2009
- Published by Wolters Kluwer Health in Critical Care Medicine
- Vol. 37 (3) , 1031-e4
Inflammatory and circulatory effects of the reduction of endotoxin concentration in established porcine endotoxemic shock—A model of endotoxin elimination
Objective: To study whether a reduction of the endotoxin load, once a generalized inflammatory state has been established, reduces the inflammatory response and endotoxin-induced effects on circulation, hypoperfusion, and organ dysfunction. Design: Prospective parallel-grouped placebo-controlled randomized interventional experimental study. Setting: University research unit. Subjects: Healthy pigs. Interventions: The animals were subjected to a continuous endotoxin infusion rate of either 4.0 or 0.063 μg endotoxin × kg−1 × h−1 for 1, 2, or 6 hours. The 1- and 2-hour infusion groups represented the applied therapy by a reduction of the endotoxin load of 5/6 and 2/3, respectively. Measurements and Main Results: During a 6-hour experiment, laboratory and physiologic parameters were recorded hourly in 26 anesthetized and mechanically ventilated pigs. Primary end point was to detect differences in tumor necrosis factor-α (TNF-α) concentration during the last 3 hours of the experiment. Despite the early reduction of the endotoxin load, no effect on TNF-α concentration was observed. Similarly, in circulatory parameters, such as mean arterial pressure and oxygen delivery, and in platelet count and renal function, no effects were noted. However, there was some improvement in pulmonary compliance and function as determined by Pao2, Paco2, and pH. These changes were associated with slight improvements in leukocyte response and capillary leakage. Conclusions: Termination of the endotoxin infusion represents an incontestable model of endotoxin concentration reduction. Endotoxin elimination strategies applied at the TNF-α peak or later will have very little or no effect on TNF-α–mediated toxicity. Nevertheless, there was an effect on the leukocyte response that was associated with an improvement in respiratory function and microcirculation, making it impossible to rule out fully the beneficial effect of this strategy. However, the effects were limited in relation to the magnitude of the endotoxin concentration reduction and the very early application of the antiendotoxin measure.